For research use only. Not for therapeutic Use.
Barucainide (CAT: C000573) is classified as an antiarrhythmic drug belonging to class Ib. It exerts its pharmacological action by selectively blocking sodium channels in cardiac cells, particularly during phase 0 of the cardiac action potential. By doing so, Barucainide can effectively decrease the conduction velocity of cardiac impulses, primarily in ischemic tissues. This property makes it useful for treating certain types of cardiac arrhythmias, particularly those that result from ischemic events. Barucainide’s mechanism of action contributes to its role in stabilizing abnormal heart rhythms and maintaining the proper rhythm of the heart’s electrical signals, thereby aiding in the management of arrhythmias.
| Catalog Number | C000573 |
| CAS Number | 79784-22-8 |
| Synonyms | 4-[[1,3-Dihydro-6-methyl-4-(phenylmethyl)furo[3,4-c]pyridin-7-yl]oxy]-N-(1-methylethyl)-1-butanamine; Furo[3,4-c]pyridine 1-Butanamine derivative; |
| Molecular Formula | C₂₂H₃₀N₂O₂ |
| Purity | ≥95% |
| Solubility | Chloroform (Slightly), Methanol (Slightly) |
| Appearance | Brown to Very Dark Brown Oil |
| Storage | 4°C |
| Reference | Takanaka, C., Singh, B.: Am. Heart J., 119, 1050 (1990); Brode, E., et al.: Methods Find. Exp. Clin. Pharmacol., 14, 717 (1992); |
